Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
BMS' CAR-T cracks down on lupus, achieving sustained responses
One patient had a grade 3 case of immune effector cell-associated neurotoxicity syndrome, an adverse event associated with CAR-T therapy.
Nick Paul Taylor
Nov 14, 2024 10:00am
VC firm, Chinese biotech launch autoimmune-focused Oblenio Bio
Nov 7, 2024 11:35am
Sanofi BTK inhibitor for blood disease raises platelet levels
Nov 5, 2024 1:42pm
Kymera pivots to immunology, seeks partners for cancer assets
Nov 1, 2024 11:46am
Jade pockets Aerovate in reverse merger
Oct 31, 2024 3:03pm
Topas says celiac candidate shines but keeps data under wraps
Oct 15, 2024 8:08am